Article
Urology & Nephrology
Mark N. Brook, Holly Ni Raghallaigh, Koveela Govindasami, Tokhir Dadaev, Reshma Rageevakumar, Diana Keating, Nafisa Hussain, Andrea Osborne, Artitaya Lophatananon, Kenneth R. Muir, Zsofia Kote-Jarai, Rosalind A. Eeles
Summary: A family history of prostate cancer is associated with an increased risk of developing the disease. This study examines how the number, degree, and age of relatives with prostate cancer are related to overall survival and prostate cancer-specific survival in prostate cancer patients.
Article
Oncology
Danielle D. Durham, Linn A. Abraham, Megan C. Roberts, Carly P. Khan, Robert A. Smith, Karla Kerlikowske, Diana L. Miglioretti
Summary: This study found that women with a first-degree family history of breast cancer diagnosed between 40 and 49 years, who underwent screening between ages 30 and 39 or 40 and 49, had similar 5-year cumulative incidences of breast cancer as women without a family history undergoing screening between 50-59 years of age. In addition, for women with a relative diagnosed at or before age 45, initiating screening 5-8 years earlier than their relative's diagnosis age resulted in a 5-year cumulative incidence of breast cancer similar to that of an average 50-year-old woman.
Article
Oncology
Traci N. Bethea, Heather M. Ochs-Balcom, Elisa V. Bandera, Alicia Beeghly-Fadiel, Fabian Camacho, Deanna Chyn, Emily K. Cloyd, Holly R. Harris, Charlotte E. Joslin, Evan Myers, Patricia G. Moorman, Lauren C. Peres, Will Rosenow, Veronica W. Setiawan, Anna H. Wu, Lynn Rosenberg, Joellen M. Schildkraut
Summary: Family history of ovarian cancer and breast cancer, especially in first-degree relatives, is strongly associated with high-grade serous ovarian carcinoma in both African American and white women, but the impact may vary by histotype among African American women.
INTERNATIONAL JOURNAL OF CANCER
(2021)
Article
Medicine, General & Internal
QiongFei Zheng, Qinli Ying, ZhengJu Ren, Qin Zhang, DongLiang Lu, HongBai Wang, WuRan Wei
Summary: Family history of prostate cancer in first-degree relatives is associated with an increased risk of breast cancer, with consistent results in subgroup analysis. Compared with no family history of prostate cancer, history of prostate cancer in first-degree relatives is associated with a slight risk of ovarian cancer. Having a family history of prostate cancer among siblings may increase the risk of ovarian cancer by 17%, while no significant association was found between family history of prostate cancer among parents and the risk of ovarian cancer.
Article
Biotechnology & Applied Microbiology
Yixin Zhang, James B. Meigs, Ching-Ti Liu, Josee Dupuis, Chloe Sarnowski
Summary: Considering family history may enhance the accuracy and power of CC-GWAS in detecting disease-associated genetic variants. The methods incorporating family history showed higher power than CC-GWAS, especially in older age groups. These methods detected known genetic variants and increased their significance in real data applications, demonstrating the importance of including family history in genetic association studies.
Article
Multidisciplinary Sciences
Laila Salameh, Bassam Mahboub, Amar Khamis, Mouza Alsharhan, Syed Hammad Tirmazy, Youssef Dairi, Qutayba Hamid, Rifat Hamoudi, Saba Al Heialy
Summary: This study suggests that asthma patients are at a higher risk of developing different types of cancers, with asthma severity and goiter being the main factors associated with increased cancer risk among asthmatic patients.
Article
Biochemistry & Molecular Biology
Xin-Yu Li, Chuan Liu, Fang-Hua Liu, Gang Zheng, Hui-Juan Yang, Yi-Fan Wei, Xue Qin, Qian Xiao, Yu-Hong Zhao, Song Gao, Ting-Ting Gong, Qi-Jun Wu
Summary: This study investigated the relationship between diet quality and survival in patients with ovarian cancer using Chinese diet quality scores. The results showed that the Chinese Healthy Eating Index was associated with improved overall survival, while the Dietary Balance Index and Chinese Food Pagoda Score were not related to survival.
Article
Oncology
Stella Koutros, Kathy L. Decker, Dalsu Baris, Larissa A. Pardo, Alison Johnson, G. M. Monawar Hosain, Nathaniel Rothman, Margaret R. Karagas, Molly R. Schwenn, Debra T. Silverman
Summary: Twin studies suggest a familial aggregation of bladder cancer, with individuals having a first-degree relative with bladder cancer having nearly double the risk of developing bladder cancer. Additionally, a family history of female genital cancer, melanoma, and tobacco-associated cancer also increased the risk of bladder cancer.
INTERNATIONAL JOURNAL OF CANCER
(2021)
Article
Oncology
Azam Majidi, Renhua Na, Susan J. Jordan, Anna DeFazio, Andreas Obermair, Michael Friedlander, Peter Grant, Penelope M. Webb
Summary: This study investigated the association between nonsteroidal antiinflammatory drug (NSAID) use and 5-year cancer-specific survival in Australian women with ovarian cancer. The results showed that frequent use of NSAIDs, including aspirin and nonaspirin NSAIDs, was associated with better survival compared to nonusers and infrequent users. These findings suggest that NSAID use might improve ovarian cancer survival.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
(2023)
Article
Medicine, General & Internal
Holli A. Loomans-Kropp, Paul Pinsky, Asad Umar
Summary: The study found that aspirin use was not associated with a reduced risk of developing breast, bladder, esophageal, gastric, pancreatic, or uterine cancers in older individuals. However, it was linked to improved survival in bladder and breast cancer patients.
Article
Multidisciplinary Sciences
Joanna Didkowska, Urszula Wojciechowska, Irmina Maria Michalek, Florentino Luciano Caetano dos Santos
Summary: The 2019 cancer report in Poland revealed that prostate and breast cancer were the most common malignant neoplasms among male and female patients, while lung cancer was one of the most deadly tumors.
SCIENTIFIC REPORTS
(2022)
Article
Oncology
Ariana Znaor, Niels Erik Skakkebaek, Ewa Rajpert-De Meyts, Tomislav Kulis, Mathieu Laversanne, Jason Gurney, Diana Sarfati, Katherine A. McGlynn, Freddie Bray
Summary: Testicular cancer is the most common cancer in young men of European ancestry and has been increasing in incidence, although mortality rates have been declining in high-income settings. Globally, testicular cancer is the most common cancer in men aged 15 to 44, with the highest incidence rates in Western, Northern, and Southern Europe and Oceania, and the lowest rates in Asia and Africa. Mortality rates are highest in Central and South America, and lowest in Northern Europe, Northern Africa, and Eastern Asia. There is significant variation in incidence and mortality rates among different countries.
INTERNATIONAL JOURNAL OF CANCER
(2022)
Article
Reproductive Biology
Jianyang Feng, Lijiang Xu, Yangping Chen, Rongjin Lin, Haoxian Li, Hong He
Summary: The incidence and mortality rates of ovarian cancer in China have been continuously increasing over the past 30 years and are predicted to continue rising in the next three decades. The estimated number of new cases and deaths from ovarian cancer is expected to triple between 2019 and 2049.
JOURNAL OF OVARIAN RESEARCH
(2023)
Article
Oncology
Hyeong In Ha, Sang-Hyun Cho, Jiwon Lim, Yeon Jee Lee, Chong Woo Yoo, Young-Joo Won, Myong Cheol Lim
Summary: The study found that the incidence of primary ovarian sarcoma is low, but the survival rate is comparable to that of epithelial ovarian cancer. Different histologic subtypes of primary ovarian sarcoma have significant differences in survival rates.
GYNECOLOGIC ONCOLOGY
(2021)
Article
Oncology
Tao Thi Tran, Jeonghee Lee, Madhawa Gunathilake, Hyunsoon Cho, Jeongseon Kim
Summary: This study aimed to investigate the influence of different fasting glucose levels on gastric cancer incidence. Through long-term observation of over 41,837 participants, it was found that high fasting glucose is associated with an increased risk of gastric cancer.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
(2022)